Retatrutide 5mg Vial
$120.00
Retatrutide 5mg lyophilized vial for advanced metabolic research. Purity ≥99% verified by HPLC and MS. Batch-specific Certificate of Analysis included. Triple-agonist peptide (GIP/GLP-1/glucagon) for weight-management studies. View full Retatrutide compound profile.
Description
Retatrutide 5mg Lyophilized Research Vial
Retatrutide is a novel triple-hormone receptor agonist targeting GIP, GLP-1, and glucagon receptors simultaneously. With CAS number 2381089-83-2, retatrutide represents the next generation of incretin-based peptides under investigation for metabolic regulation and energy expenditure. This 5mg lyophilized vial provides a standard research quantity for initial studies and dose-finding protocols.
Product Specifications
- Quantity: 5 mg per vial
- Form: Lyophilized (freeze-dried) powder
- Purity: ≥99% by HPLC
- CAS: 2381089-83-2
Quality Assurance
Each retatrutide batch is verified through HPLC and mass spectrometry (MS) analysis. A batch-specific Certificate of Analysis (COA) accompanies every order. Explore our testing methodology and COA interpretation guide.
Storage & Handling
Store lyophilized retatrutide at -20°C for optimal stability. Reconstituted solutions should be held at 2-8°C, protected from light, and used within 14 days. See our peptide storage and shipping guide.
Wholesale & Bulk Pricing
Wholesale pricing available for qualified research organizations and distributors. Visit our Retatrutide wholesale page or apply to the wholesale program. Also available in 10mg vial format.
Browse our Weight Management catalog.
For laboratory research use only. Not for human consumption.
Reviews
There are no reviews yet.